tbuckley/cabot-search huggingface dataset:
Chemotherapy vs. immunotherapy as neoadjuvant therapies in cisplatin-eligible patients undergoing radical cystectomy for muscle invasive bladder cancer
Authors: L. Nocera, M. Bandini, G. Basile, M. Moschini, S.U. Naidu, K.M. Rose, R. Li, P. Spiess, A. Necchi
Journal: European Urology (2023)
Functional outcomes prediction after robotic partial nephrectomy using PADUA score assessed with 3D virtual models: Preliminary results of a collaborative ERUS study
Authors: D. Amparore, F. Pira, A. Piana, E. Checcucci, G. Basile, A. Larcher, A. Gallioli, A. Territo, J. Gaya, P. Piazza, S. Puliatti, A. Grosso, A. Mari, R. Campi, S. Serni, U. Capitanio, F. Montorsi, A. Mottrie, C. Fiori, A. Minervini, A. Breda, F. Porpiglia
Journal: European Urology (2023)
Can experience of blue light cystoscopy improve a surgeon’s white light resection? Data from the PHOTO trial
Authors: P. Gravestock, T. Vadiveloo, R. Lewis, G. Yu, P. Mariappan, J. Cresswell, J. Mcgrath, G. Nabi, H. Mostafid, H. Lazarowicz, J. Kelly, A. Duncan, S. Penager, E. Clark, A. Feber, G. Orozco-Leal, Z. Tandogdu, J. N’Dow, J. Norrie, C. Ramsay, S. Rice, L. Vale, G. Maclennan, E. Hall, R. Heer
Journal: European Urology (2023)
When is central histological review of prostate biopsy really needed to reduce the risk of misclassification of prostate cancer? The importance of patient risk stratification
Authors: A. Pellegrino, F. Pellegrino, G. Gandaglia, S. Scuderi, R. Lucianò, N. Tenace, F. Paparesta, L. Pepi, L. Quarta, E. Mazzone, F. Barletta, G.O. Cirulli, D. Robesti, G. Sorce, C.A. Bravi, L. Nocera, A. Stabile, R. Montironi, F. Montorsi, A. Briganti
Journal: European Urology (2023)
In pediatric patients with an upper tract urinary stone of less than 2cm in diameter does ureteroscopy compared to shock wave lithotripsy improves the stone-free rate? A systematic review and meta-analysis from the EAU Urolithiasis Pannel
Authors: R. Geraghty, R. Lombardo, L. Tzelves, N.F. Davis, A. Neisius, A. Petřík, G. Gambaro, H. Ulrik Jung, A. Skolarikos, T. Tailly, B. Somani
Journal: European Urology (2023)
Asymptomatic bacteriuria does not increase the risk of infective complications in patients with non-muscle-invasive bladder cancer undergoing intravesical bacillus calmette-guérin immunotherapy
Authors: A. Nummi, P. Nurminen, O. Kesti, M. Högerman, O. Ettala, A. Kaipia, P. Boström, J. Sairanen, R. Järvinen
Journal: European Urology (2023)
Bifidobacterium species BB_003 enhances antitumor immunity in patients with NMIBC and improve recurrence-free survival
Authors: K. Min, X-M. Piao, S-K. Kim, S-H. Park, H.W. Kang, W.T. Kim, K. Kim, H.P. Park, S.J. Yun
Journal: European Urology (2023)
Association of age with non-muscle-invasive bladder cancer: A biological basis for epidemiological disparities?
Authors: N. Lobo, A. Sood, Z. Duan, W.S. Tan, V. Grajales, S. Viborg Lindskrog, L. Dyrskjøt, H. Zhao, S. Giordano, S.B. Williams, A.M. Kamat
Journal: European Urology (2023)
Circumferential stricture segment metaplastic squamous mucosa &amp; associated spongiofibrosis excision and urethroplasty by ventral approach with double face oral mucosal graft replacement
Authors: A.D. Dangi, A. Debnath, S. Kishore, S. Jat, F. Mudasir, T.J. Nirmal, R.P. Mukha, J. Chandrasingh, S. Kumar, J. N’Dow
Journal: European Urology (2023)
Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?
Authors: R. Leni, A. Stabile, G. Gandaglia, E. Mazzone, V. Cucchiara, G. Rosiello, G. Sorce, D. Robesti, M. De Angelis, S. Scuderi, D. Cannoletta, G. Brembilla, A. Esposito, F. De Cobelli, F. Montorsi, A. Briganti
Journal: European Urology (2023)
Drained versus non-drained inflatable penile prosthesis implantation: A multicenter prospective pilot study
Authors: D. Osmonov, A. Ragheb, T. Petry, A. Eraky, C. Bettocchi, G. Lamers, M. Tropmann-Frick, G. Garaffa, H. Porst, A. Mohamed, S. Wilson
Journal: European Urology (2023)
Left robot-assisted upper pole heminephrectomy for upper urinary tract urothelial cancer in lynch syndrom
Authors: A. Khaddad, X. Lacroix, G. Margue, E. Alezra, V. Estrade, G. Capon, F. Bladou, G. Robert, J.J. Patard, J.C. Bernhard
Journal: European Urology (2023)
Prognostic impact of CD73/adenosine receptor 2 (A2aR) in renal cell carcinoma and immune microenvironmental status with sarcomatoid changes and rhabdoid features
Authors: D. Takamatsu, D. Kiyozawa, K. Kohashi, S. Goto, F. Kinoshita, T. Matsumoto, K. Ri, K. Monji, E. Kashiwagi, M. Shiota, J. Inokuchi, Y. Oda, M. Eto
Journal: European Urology (2023)
IFNγ-mediated stimulation of PD-L1 expression on exosomes in urological malignancies and their effect on CD8+ T cells
Authors: G. Jaschkowitz, M. Haid, D. Himbert, A. Zaccagnino, M. Stöckle, E. Noessner, K. Junker, P. Zeuschner
Journal: European Urology (2023)
Adenocarcinoma of the bladder: Assessment of survival benefit associated with radical cystectomy and comparison with urothelial bladder cancer
Authors: S. Tappero, F. Barletta, M. Piccinelli, C. Cano Garcia, R-B. Incesu, S. Morra, F. Chierigo, Z. Tian, S. Parodi, P. Dell’Oglio, A. Briganti, O. De Cobelli, F.K.H. Chun, M. Graefen, V. Mirone, F. Saad, S.F. Shariat, N.R. Suardi, M. Borghesi, C. Terrone, P.I. Karakiewicz
Journal: European Urology (2023)
Gender bias in urology: How do patients really choose their urologist?
Authors: A. Tamalunas, P. Lenau, L.F. Stadelmeier, J-N. Mumm, T. Vilsmaier, H. Höhn, M. Mumm, R. Waidelich, J. Casuscelli, G. Magistro, A. Buchner, T. Kolben, C.G. Stief, M. Hennenberg
Journal: European Urology (2023)
Survival after radical prostatectomy vs. radiation therapy in clinical node positive prostate cancer patients: A multicentric study
Authors: F. Chierigo, C. Scaffidi, A. Porcaro, D. Amparore, R. Bertolo, C.A. Bravi, G. Bozzini, C. Trombetta, E. Mearini, E. Montanari, P. Ditonno, A. Simonato, P. Bove, C. De Nunzio, A. Tubaro, R. Schiavina, E. Brunocilla, A. Antonelli, A. Galosi, A. Mottrie, F. Porpiglia, S. Barra, M. Borghesi, C. Terrone
Journal: European Urology (2023)
Prospective trial of Cefixime vs. Fosfomycin in prostate biopsy
Authors: D. Vieira E Brito, M.P. Pedrosa, J.P. Pereira, A. Ferreira, M.P.L. Pereira, R.G. Godinho, B. Pereira, P.P. Peralta, P.C. Conceição, M.R. Reis, C. Rabaça
Journal: European Urology (2023)
Comparing Retrograde Intrarenal Surgery (RIRS) outcomes between pre-stented vs non-stented patients Inferences from 6679 patients of the global FLEXible ureteroscopy Outcomes Registry (FLEXOR)
Authors: C. Chu Ann, B.K. Somani, J. Yuen-Chun Teoh, T. Tailly, E. Emiliani, T. Inoue, Y. Tanidir, N. Gadzhiev, S. Bin Hamri, W.O. Lay Keat, A. Shrestha, D. Ragoori, M.A. Lakmichi, D. Gorelov, B. Soebhali, C.M. Vaddi, T.P. Bhatia, D. Desai, P. Durai, C.T. Heng, B.H. Chew, D. Castellani, O. Traxer, V. Gauhar
Journal: European Urology (2023)
Development of a nomogram to predict benign pathology in a large series of minimally invasive partial nephrectomy
Authors: A. Uleri, M. Baboudjian, A. Gallioli, A. Territo, J. Gaya, O. Rodriguez-Faba, A. Rosales, G. Basile, P. Verri, A. Tedde, I. Sanz, M. Casadevall, A. Farré, J. Palou, A. Breda
Journal: European Urology (2023)
Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma: A population-based study
Authors: F. Liedberg, O. Hagberg, C. Häggström, F. Aljabery, T. Gårdmark, A. Hosseini, S. Jahnson, T. Jerlström, V. Ströck, K. Söderkvist, A. Ullén, L. Holmberg, J. Bobjer
Journal: European Urology (2023)
Extracorporeal shock wave lithotripsy: Effectiveness and factors related to stone fragmentation and hematoma
Authors: A.C. Tagalos Munoz, I. Laso Garcia, P. Del Olmo Durán, C. Mínguez Ojeda, M. Mata Alcaraz, D. López Curtis, E. López Perez, G. Duque Ruiz, M. Hevia Palacios, F. Arias Fúnez, F.J. Burgos Revilla
Journal: European Urology (2023)
Usefulness of stone culture in endoscopic combined intra-renal surgery
Authors: T. Etani, T. Morikawa, M. Gonda, M. Aoki, T. Nagai, K. Iida, K. Taguchi, T. Naiki, S. Hamamoto, A. Okada, N. Kawai, T. Yasui
Journal: European Urology (2023)
Global Incidence, Risk Factors, and Temporal Trends of Mesothelioma: A Population-Based Study
Authors: Junjie Huang, Sze Chai Chan, Wing Sze Pang, Shui Hang Chow, Veeleah Lok, Lin Zhang, Xu Lin, Don Eliseo Lucero-Prisno, Wanghong Xu, Zhi-Jie Zheng, Edmar Elcarte, Mellissa Withers, Martin C.S. Wong
Journal: Journal of Thoracic Oncology (2023)

Mesothelioma is an uncommon type of cancer which has received little attention. This study aims to evaluate the global disease burden; trends of mesothelioma by age, sex, and geographic locations; and its risk factors on the population level.The Global Cancer Observatory, Cancer Incidence in Five Continents Plus, and Global Burden of Disease were accessed for mesothelioma incidence and its risk factors worldwide. The associations between mesothelioma incidence and asbestos were evaluated for each country by multivariable linear regression analysis by sex and age. Average annual percentage change (AAPC) was calculated using Joinpoint regression to evaluate the epidemiologic trends of mesothelioma.The age-standardized rate of mesothelioma was 0.30 per 100,000 persons with Northern Europe reporting the highest incidence rates. The incidence rate of the male population was much higher than that of the females. Countries with higher human development index (β = 0.119, confidence interval [CI]: 0.073-0.166, p < 0.001), gross domestic product per capita (β = 0.133, CI: 0.106-0.161, p < 0.001), and asbestos exposure (β = 0.087, CI: 0.073-0.102, p < 0.001) had higher mesothelioma. The overall trend of mesothelioma incidence was decreasing, although an increase was observed in Bulgaria (AAPC: 5.56, 95% CI: 2.94-8.24, p = 0.001) and Korea (AAPC: 3.24, 95% CI: 0.08-6.49, p = 0.045).There was a substantial declining incidence trend of mesothelioma in the past decade possibly related to the restriction of the use of asbestos in some countries. Meanwhile, the increasing trend in mesothelioma incidence observed in females might be indicative of an increase in environmental exposure to mineral fibers.
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
Authors: Joao V. Alessi, Arielle Elkrief, Biagio Ricciuti, Xinan Wang, Alessio Cortellini, Victor R. Vaz, Giuseppe Lamberti, Rosa L. Frias, Deepti Venkatraman, Claudia A.M. Fulgenzi, Federica Pecci, Gonzalo Recondo, Alessandro Di Federico, Adriana Barrichello, Hyesun Park, Mizuki Nishino, Grace M. Hambelton, Jacklynn V. Egger, Marc Ladanyi, Subba Digumarthy, Bruce E. Johnson, David C. Christiani, Xihong Lin, Justin F. Gainor, Jessica J. Lin, David J. Pinato, Adam J. Schoenfeld, Mark M. Awad
Journal: Journal of Thoracic Oncology (2023)
Ranking pharmaceutical companies on clinical trial diversity
Authors: Tanvee Varma, Jennifer E Miller
Journal: BMJ (2023)

It is well established that women, older adults, and people from racial and ethnic minorities are under-represented in clinical trials. 1 -3 Clinical trial participants are more often male, white, and tend to be younger and healthier than real world patients.This lack of diversity in research can provoke questions about the safety and effectiveness of novel therapeutics in under-represented populations, as well as raising important public health and social justice concerns. 4 In the US, policy efforts to improve the diversity of clinical trials have been attempted across the past few decades.The National Institutes of Health Revitalization Act, signed into law in 1993, the 21st Century Cures Act, and numerous guidance documents published by the US Food and Drug Administration (FDA) in recent years, are just a few examples. 5 -7 Most recently, the US Congress end-of-year spending, or omnibus, bill for 2022 contained provisions to advance diversity in clinical trials.Yet so far these efforts have had limited impact, suggesting additional strategies are needed.
Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Review and Meta-Analysis
Authors: Natthaya Triphuridet, Shannon S. Zhang, Misako Nagasaka, Yanfei Gao, Joseph J. Zhao, Nicholas L. Syn, Takaomi Hanaoka, Sai-Hong Ignatius Ou, Elaine Shum
Journal: Journal of Thoracic Oncology (2023)

Lung cancer in never-smokers is the major cancer cause of death globally. We compared the efficacy of low-dose computed tomography (LDCT) lung cancer screening among never-smokers versus ever-smokers using systematic review and meta-analysis.LDCT lung cancer screening studies that simultaneously included both ever-smoker and never-smoker participants published by April 30, 2021, were searched through PubMed and Scopus. Primary outcome measure was relative risk (RR) of lung cancer diagnosed among never-smokers versus ever-smokers.A total of 14 studies (13 from Asia) were included (141,396 ever-smokers, 109,251 never-smokers, 1961 lung cancer cases diagnosed). RR of lung cancer diagnosed between ever-smokers versus never-smokers overall was 1.21 (95% confidence interval [CI]: 0.89-1.65), 1.37 (95% CI: 1.08-1.75) among males, and 0.88 (95% CI: 0.59-1.31) among females. RR was 1.78 (95% CI: 1.41-2.24) and 1.22 (95% CI: 0.89-1.68) for Asian female never-smokers versus male never-smokers and versus male ever-smokers, respectively, and 0.99 (95% CI: 0.65-1.50) versus high-risk ever-smokers (≥30 pack-years). Proportional meta-analysis revealed significantly more lung cancers diagnosed at first scan (95.4% [95% CI: 84.9-100.0] versus 70.9% [95% CI: 54.6-84.9], p = 0.010) and at stage 1 (88.5% [95% CI: 79.3-95.4] versus 79.7% [95% CI: 71.1-87.4], p = 0.071) among never-smokers versus ever-smokers, respectively. RR of lung cancer death and 5-year all-cause mortality in never-smokers versus ever-smokers was 0.27 (95% CI: 0.1-0.55, p < 0.001) and 0.13 (95% CI: 0.05-0.33, p < 0.001), respectively.The RR of lung cancer detected by LDCT screening among female never-smokers and male ever-smokers in Asia was statistically similar. Overall and lung cancer specific mortality from the lung cancer diagnosed from LDCT screening was significantly reduced among never-smokers compared to ever-smokers.
Attachment patterns and autobiographical episodic memory functioning: A systemic review of adult studies to advance clinical psychological science
Authors: A. Lau-Zhu, F. Williams, C. Steel
Journal: Clinical Psychology Review (2023)

Patterns of insecure attachment are associated with psychopathology but the mechanisms involved remain poorly understood. Cognitive science proposes that attachment patterns are influenced by the autobiographical memory system and in turn influence its ongoing functioning. Disturbances in autobiographical memory represent cognitive risks for later emotional difficulties. We systemically reviewed 33 studies (in 28 articles) examining the association between attachment patterns and autobiographical episodic memory (AEM) in individuals from the age of 16 (i.e., from young to older adulthood). Attachment patterns were associated with key areas of AEM phenomenology, including intensity and arousal; detail, specificity, and vividness; coherence and fragmentation; and accuracy and latency. These associations appeared to be moderated by contextual and individual factors; mediated by emotional regulation and schema-based processing; linked to mental health outcomes. Attachment patterns may also influence the impact of certain AEM-based manipulations. We conclude by providing a critical discussion and a research agenda for bringing together attachment, memory, and emotion, with a view to promote mechanism-driven treatment innovation in clinical psychology.
Trends in the Prevalence of Lean Diabetes Among U.S. Adults, 2015–2020
Authors: Taiwo P. Adesoba, Clare C. Brown
Journal: Diabetes Care (2023)

To examine trends and prevalence of lean diabetes among adults in the U.S. from 2015 to 2020, overall and stratified by age, sex, and race/ethnicity.An exploratory study design evaluated the prevalence and trends of lean diabetes among 2,630,463 (unweighted) adults aged ≥18 years who responded to the Behavioral Risk Factor Surveillance System (BRFSS), years 2015 to 2020.Diabetes increased significantly among lean adults with BMI of <25 kg/m2 from 4.5% (95% CI 4.3-4.7) in 2015 to 5.3% (95% CI 5.0-5.7) in 2020, representing a 17.8% increase (odds ratio 1.21; 95% CI 1.12-1.31), with no significant change among overweight/obese adults. Increases in diabetes prevalence among lean adults varied by subgroup with Black, Hispanic, and female populations seeing the largest growth.The prevalence of lean diabetes among the U.S. adult population is increasing, with larger increases among women and populations of color.
Cancer burden among adolescents and young adults in relation to childhood adversity: a nationwide life-course cohort study of 1.2 million individuals
Authors: Naja Hulvej Rod, Jessica Bengtsson, Leonie K. Elsenburg, Megan Davies, David Taylor-Robinson, Samir Bhatt, Andreas Rieckmann
Journal: The Lancet Regional Health - Europe (2023)

Childhood adversity such as poverty, loss of a parent, and dysfunctional family dynamics may be associated with exposure to environmental and behavioral hazards, interfere with normal biological functions, and affect cancer care and outcomes. To explore this hypothesis, we assessed the cancer burden among young men and women exposed to adversity during childhood.We undertook a population-based study using Danish nationwide register data on childhood adversity and cancer outcomes. Children who were alive and resident in Denmark until their 16th birthday were followed into young adulthood (16-38 years). Group-based multi-trajectory modelling was used to categorize individuals into five distinct groups: low adversity, early material deprivation, persistent material deprivation, loss/threat of loss, and high adversity. We assessed the association with overall cancer incidence, mortality, and five-year case fatality; and cancer specific outcomes for the four most common cancers in this age group in sex-stratified survival analyses.1,281,334 individuals born between Jan 1, 1980, and Dec 31, 2001, were followed up until Dec 31, 2018, capturing 8229 incident cancer cases and 662 cancer deaths. Compared to low adversity, women who experienced persistent material deprivation carried a slightly lower risk of overall cancer (hazard ratio (HR) 0.90; 95% CI 0.82; 0.99), particularly due to malignant melanoma and brain and central nervous system cancers, while women who experienced high adversity carried a higher risk of breast cancer (HR 1.71; 95% CI 1.09; 2.70) and cervical cancer incidence (HR 1.82; 95% CI 1.18; 2.83). While there was no clear association between childhood adversity and cancer incidence in men, those men who had experienced persistent material deprivation (HR 1.72; 95% CI 1.29; 2.31) or high adversity (HR 2.27; 95% CI 1.38; 3.72) carried a disproportionate burden of cancer mortality during adolescence or young adulthood compared to men in the low adversity group.Childhood adversity is associated with a lower risk of some subtypes of cancer and a higher risk of others, particular in women. Persistent deprivation and adversity are also associated with a higher risk of adverse cancer outcomes for men. These findings may relate to a combination of biological susceptibility, health behaviors and treatment-related factors.None.
Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma
Authors: Nishanth Ulhas Nair, Qun Jiang, Jun Stephen Wei, Vikram Alexander Misra, Betsy Morrow, Chimene Kesserwan, Leandro C. Hermida, Joo Sang Lee, Idrees Mian, Jingli Zhang, Alexandra Lebensohn, Markku Miettinen, Manjistha Sengupta, Javed Khan, Eytan Ruppin, Raffit Hassan
Journal: Cell Reports Medicine (2023)

Malignant mesothelioma is an aggressive cancer with limited treatment options and poor prognosis. A better understanding of mesothelioma genomics and transcriptomics could advance therapies. Here, we present a mesothelioma cohort of 122 patients along with their germline and tumor whole-exome and tumor RNA sequencing data as well as phenotypic and drug response information. We identify a 48-gene prognostic signature that is highly predictive of mesothelioma patient survival, including CCNB1, the expression of which is highly predictive of patient survival on its own. In addition, we analyze the transcriptomics data to study the tumor immune microenvironment and identify synthetic-lethality-based signatures predictive of response to therapy. This germline and somatic whole-exome sequencing as well as transcriptomics data from the same patient are a valuable resource to address important biological questions, including prognostic biomarkers and determinants of treatment response in mesothelioma.
Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial
Authors: R. Waziry, C. P. Ryan, D. L. Corcoran, K. M. Huffman, M. S. Kobor, M. Kothari, G. H. Graf, V. B. Kraus, W. E. Kraus, D. T. S. Lin, C. F. Pieper, M. E. Ramaker, M. Bhapkar, S. K. Das, L. Ferrucci, W. J. Hastings, M. Kebbe, D. C. Parker, S. B. Racette, I. Shalev, B. Schilling, D. W. Belsky
Journal: Nature Aging (2023)

The geroscience hypothesis proposes that therapy to slow or reverse molecular changes that occur with aging can delay or prevent multiple chronic diseases and extend healthy lifespan
Initial experience of robot-assisted partial nephrectomy with Hugo RAS™ system: Implications for surgical setting
Authors: A. Uleri, G. Basile, J.M. Gaya, A. Territo, A. Gallioli, P. Verri, P. Gavrilov, J. Aumatell, S. Fontanet, R. Sanchez Molina, A. Tedde, J. Palou, A. Breda
Journal: European Urology (2023)
Non-absorbable clip migration after robot-assisted partial nephrectomy: A rare but challenging complication
Authors: G. Basile, G. Fallara, G. Rosiello, C. Re, G. Musso, F. Cei, F. Belladelli, D. Cignoli, A. Briganti, L. Villa, E. Ventimiglia, A. Salonia, F. Montorsi, A. Larcher, U. Capitanio
Journal: European Urology (2023)
Real-time detection of lymph leak during inguinal lymph node dissection using ICG lymphography guidance based on lower-limb lymphatic pathway studies
Authors: Y. Komai, Y. Fuse, Y. Yoneoka, R. Fujiwara, Y. Yasuda, T. Oguchi, N. Numao, S. Yamamoto, T. Yano, J. Yonese
Journal: European Urology (2023)
Finals results in the safety and performance evaluation of a drop-in gamma probe for sentinel lymph node dissection in prostate cancer
Authors: L. Polaina Barroso, W. Everaerts, J.C. Walz, L. Cecchini, J.M. Abascal Junquera, C. Solà Marqués, K. Goffin, K. Van Het Klooster, S. Vidal-Sicart, A. Mestre Fusco, R. Valhondo, L. Fumadó
Journal: European Urology (2023)
Improving the safety of robotic surgery with a new artificial intelligence-based system
Authors: E. Checcucci, S. De Cillis, D. Amparore, G. Volpi, F. Piramide, A. Piana, M. Sica, D. Zamengo, M. Manfredi, C. Fiori, P. Piazzolla, F. Porpiglia
Journal: European Urology (2023)
Near miss in robot-assisted partial nephrectomy. Prevention of adverse events by careful identification of the surgical anatomy
Authors: S. Parodi, S. Tappero, G. Guano, A. Pacchetti, F. Chierigo, F. Ambrosini, A. Caviglia, M. Beverini, S. Rebuffo, G. Mantica, M. Borghesi, C. Terrone
Journal: European Urology (2023)
3D augmented reality robotic-assisted segmental ureterectomy with buccal mucosa graft for the repair of upper complex ureteral strictures
Authors: A. Piana, D. Amparore, G. Busacca, P. Alessio, E. Checcucci, F. Piramide, S. De Cillis, G. Volpi, P. Verri, M. Sica, M. Burgio, A. Bellin, M. Manfredi, C. Fiori, F. Porpiglia
Journal: European Urology (2023)
Management of atypical recurrence after treatment of localized renal cell carcinoma: Retrograde intrarenal surgery as an option
Authors: L. Villa, G. Sorce, G. Fallara, E. Ventimiglia, G. Rosiello, G. Musso, F. Cei, C. Re, R. Lucianò, N.P. Tenace, A. Larcher, L.M. Vitale, A. Salonia, A. Briganti, F. Montorsi, R. Bertini, U. Capitanio
Journal: European Urology (2023)